Skip to main content
Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc. — Investor Relations & Filings

Ticker · ALLO ISIN · US0197701065 US Manufacturing
Open in API
Filings indexed 523 across all filing types
Latest filing 2019-06-25 Director's Dealing
Country US United States of America
Listing US ALLO

About Allogene Therapeutics, Inc.

https://allogene.com/

Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies. The company engineers T cells from healthy donors to create "off-the-shelf" treatments for cancer and autoimmune diseases. This approach is designed to enable on-demand availability, scalability, and reliability, contrasting with autologous therapies that use a patient's own cells. Allogene's pipeline utilizes multiplex gene-engineering and gene-editing capabilities. Its key investigational programs include cemacabtagene ansegedleucel (cema-cel) for large B-cell lymphoma, ALLO-316 for clear cell renal cell carcinoma, and ALLO-329 for autoimmune disease.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2019-06-25 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated June 6, 2019, by Allogene Therapeutics, Inc. The content focuses on the submission of matters to a vote of security holders at the 2019 Annual Meeting of Stockholders, including election of directors and ratification of the independent registered public accounting firm. It provides detailed voting results for these proposals. The document is relatively short (3929 characters) and is not a full annual report or financial statement. It is specifically reporting the official results of shareholder votes at a general meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-06-10 English
FORM 4 SUBMISSION
Director's Dealing
2019-06-05 English
FORM 4 SUBMISSION
Director's Dealing
2019-05-15 English
FORM 4 SUBMISSION
Director's Dealing
2019-05-15 English
SC13D/A
Major Shareholding Notification
2019-05-15 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.